David Pendarvis - Feb 3, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administration Officer
Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Feb 3, 2022
Transactions value $
-$359,551
Form type
4
Date filed
2/4/2022, 06:14 PM
Previous filing
Jan 4, 2022
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$360K -1.54K -1.33% $232.87 114K Feb 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.